News
28 August, 2024
Coeliac trial call
The University of the Sunshine Coast (UniSC) Clinical Trials clinic in Moreton Bay is preparing to trial a new treatment aimed at helping those with coeliac disease, a prevalent immune-based condition triggered by gluten.
Affecting one in 70 Australians, coeliac disease forces those diagnosed to adhere strictly to a gluten-free diet.
However, despite these efforts, many continue to experience symptoms related to the condition.
Dr Ivan Lim, Principal Investigator at the Morayfield clinic, highlighted the ongoing challenges faced by coeliac patients.
“While adhering to a gluten-free diet is imperative for individuals diagnosed with the condition, some people continue to experience symptoms associated with coeliac disease,” Dr Lim said.
Recognising the need for more effective treatments, UniSC Clinical Trials has partnered with a pharmaceutical company to assess the safety of a new single-dose investigational treatment.
This trial is specifically designed for coeliac disease patients who still face gluten-related challenges despite their best eff orts to avoid gluten.
The upcoming trial follows previous clinical research conducted by the UniSC team, which has garnered significant interest from the coeliac community.
“Following our previous clinical trials related to this prevalent disease, we know there are a lot of diagnosed coeliacs who are keen to help researchers find effective treatments,” Dr Lim added.
UniSC Clinical Trials Coordinator Charlaine Reeve emphasised the need for volunteers to participate in this crucial study.
The team is seeking individuals aged between 18 and 70 who have been medically diagnosed with coeliac disease and have a Body Mass Index (BMI) between 18 and 35.
“We encourage eligible participants to apply through our website if they can commit to 13 visits at our Morayfield clinic over six months,” Mr Reeve said.
The trial offers a unique opportunity for coeliac patients to contribute to potentially ground-breaking research that could lead to more effective treatments for managing their condition.
Interested individuals can fi nd more information and apply to participate through the UniSC Clinical Trials website.
